SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-054671
Filing Date
2010-03-12
Accepted
2010-03-12 09:06:03
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 5174912
2 ARTICLES OF ASSOCIATION (STATUTS) OF SANOFI-AVENTIS (ENGLISH TRANSLATION) dex11.htm EX-1.1 45688
3 CERTIFICATION OF CHRISTOPHER VIEHBACHER, CEO, REQUIRED BY SECTION 302. dex121.htm EX-12.1 9496
4 CERTIFICATION OF JEROME CONTAMINE, PFO, REQUIRED BY SECTION 302. dex122.htm EX-12.2 10578
5 CERTIFICATION OF CHRISTOPHER VIEHBACHER, CEO, REQUIRED BY SECTION 906. dex131.htm EX-13.1 2989
6 CERTIFICATION OF JEROME CONTAMINE, PFO, REQUIRED BY SECTION 906. dex132.htm EX-13.2 4196
7 CONSENT OF ERNST & YOUNG AUDIT dex231.htm EX-23.1 1788
8 CONSENT OF PRICEWATERHOUSECOOPERS AUDIT dex232.htm EX-23.2 2114
9 REPORT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR 2009. dex991.htm EX-99.1 67940
10 GRAPHIC g96846g77l24.jpg GRAPHIC 50014
  Complete submission text file 0001193125-10-054671.txt   5390229
Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 10675925
SIC: 2834 Pharmaceutical Preparations